The S&P 500 closed in a correction on Thursday, ending the day more than 10% off its high, as stocks headed for weekly losses. What’s on CNBC’s radar Friday.
Two stocks for investors’ buy lists during this sell-off, according to Tim Seymour
The market sell-off could be a buying opportunity for these two names, according to Tim Seymour of Seymour Asset Management.
Morningstar likes these solid dividend payers when markets get choppy
A trio of real estate investment trusts could provide solid prospects for income. Two of them are dividend aristocrats.
Retail investors can’t quit their love for Tesla
Everyday investors cumulatively bought $4.1 billion in stock of the electric vehicle maker since March 4, even as the stock plunged.
Josh Brown gives 4 of the best stocks out there as market craters
Thursday, the S&P 500 had fallen 10% from its recent high, entering a correction. Investors faced continued uncertainty about President Trump’s trade policy.
S&P 500 has further downside ahead, according to three chart indicators
David Keller breaks down key breadth signals on the benchmark.
These are the biggest worries rocking the market in a tumultuous week
Investors fear that a lack of clarity around trade policy, growing economic uncertainty and a rising federal deficit are raising the potential for a recession.
50% declines are commonplace for Tesla shares. How to trade the stock from here
Mike Khouw analyzes the investor sentiment on Tesla and how to trade it with options.
Analysts cheer Intel CEO pick, but few are saying buy the stock
Intel has chosen a new chief executive, and analysts feel that it was a step in the right direction for the once-dominant U.S. chipmaker.
This biotech stock is a buy thanks to its cancer treatment pipeline, Citi says
Biontech has a promising cancer treatment pipeline, per Citi.